Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $995000.0.

  • Ultralife's Capital Expenditures rose 6750.84% to $995000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 5426.86%. This contributed to the annual value of $1.9 million for FY2024, which is 2429.47% down from last year.
  • As of Q3 2025, Ultralife's Capital Expenditures stood at $995000.0, which was up 6750.84% from $1.1 million recorded in Q2 2025.
  • Ultralife's 5-year Capital Expenditures high stood at $1.1 million for Q2 2025, and its period low was $360000.0 during Q2 2024.
  • Moreover, its 4-year median value for Capital Expenditures was $564000.0 (2023), whereas its average is $663583.3.
  • As far as peak fluctuations go, Ultralife's Capital Expenditures crashed by 3970.15% in 2024, and later soared by 20555.56% in 2025.
  • Ultralife's Capital Expenditures (Quarter) stood at $489000.0 in 2021, then surged by 105.52% to $1.0 million in 2023, then crashed by 39.7% to $606000.0 in 2024, then surged by 64.19% to $995000.0 in 2025.
  • Its last three reported values are $995000.0 in Q3 2025, $1.1 million for Q2 2025, and $895000.0 during Q1 2025.